Empagliflozin Improves Atherosclerosis by Promoting Mitophagy in Endothelial Cells.

Yan L, Lu J, Xu W, Dong R

DOI: 10.1007/s10557-026-07938-8
Published: 2026 Sep 1
Container: Cardiovascular drugs and therapy
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10557-026-07938-8,
  title = {Empagliflozin Improves Atherosclerosis by Promoting Mitophagy in Endothelial Cells.},
  author = {Yan L and Lu J and Xu W and Dong R},
  year = {2026},
  journal = {Cardiovascular drugs and therapy},
  doi = {10.1007/s10557-026-07938-8},
  url = {https://doi.org/10.1007/s10557-026-07938-8}
}

RIS

TY  - JOUR
TI  - Empagliflozin Improves Atherosclerosis by Promoting Mitophagy in Endothelial Cells.
AU  - Yan L
AU  - Lu J
AU  - Xu W
AU  - Dong R
PY  - 2026
JO  - Cardiovascular drugs and therapy
DO  - 10.1007/s10557-026-07938-8
UR  - https://doi.org/10.1007/s10557-026-07938-8
ER  -

APA

L, Y., J, L., W, X., & R, D. (2026). Empagliflozin Improves Atherosclerosis by Promoting Mitophagy in Endothelial Cells.. Cardiovascular drugs and therapy. https://doi.org/10.1007/s10557-026-07938-8

Source records

pubmed · retrieved 2026-09-25T18:11:05.988Z
europe-pmc · retrieved 2026-09-25T18:11:05.987Z